{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T12:47:12Z","timestamp":1784551632736,"version":"3.55.0"},"reference-count":21,"publisher":"International Research and Cooperation Association for Bio & Socio-Sciences Advancement (IRCA-BSSA)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BST"],"published-print":{"date-parts":[[2018,8,31]]},"DOI":"10.5582\/bst.2018.01117","type":"journal-article","created":{"date-parts":[[2018,8,26]],"date-time":"2018-08-26T22:32:23Z","timestamp":1535322743000},"page":"389-394","source":"Crossref","is-referenced-by-count":20,"title":["Downregulation of lncRNA TUG1 is involved in ankylosing spondylitis and is related to disease activity and course of treatment"],"prefix":"10.5582","volume":"12","author":[{"given":"Xiaoyong","family":"Lan","sequence":"first","affiliation":[{"name":"Department of Orthopedics, The Third Affiliated Hospital of Nanchang University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiping","family":"Ma","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, The Second Affiliated Hospital of Nanchang University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiping","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Orthopedics, The Third Affiliated Hospital of Nanchang University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Ye","sequence":"additional","affiliation":[{"name":"Department of Orthopedics, The Third Affiliated Hospital of Nanchang University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Min","sequence":"additional","affiliation":[{"name":"Department of Rehabilitation, The Third Affiliated Hospital of Nanchang University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Cai","sequence":"additional","affiliation":[{"name":"Department of Orthopedics, The Third Affiliated Hospital of Nanchang University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Luo","sequence":"additional","affiliation":[{"name":"Department of Rehabilitation, The Second Affiliated Hospital of Nanchang University"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3542","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Jang JH, Ward MM, Rucker AN, Reveille JD, Davis JC, Jr., Weisman MH, Learch TJ. Ankylosing spondylitis: Patterns of radiographic involvement--a re-examination of accepted principles in a cohort of 769 patients. Radiology. 2011; 258:192-198.","DOI":"10.1148\/radiol.10100426"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Gao X, Wendling D, Botteman MF, Carter JA, Rao S, Cifaldi M. Clinical and economic burden of extra-articular manifestations in ankylosing spondylitis patients treated with anti-tumor necrosis factor agents. J Med Econ. 2012; 15:1054-1063.","DOI":"10.3111\/13696998.2012.692341"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Kiltz U, van der Heijde D, Mielants H, Feldtkeller E, Braun J, group PEpi. ASAS\/EULAR recommendations for the management of ankylosing spondylitis: The patient version. Ann Rheum Dis. 2009; 68:1381-1386.","DOI":"10.1136\/ard.2008.096073"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Davis JC, Jr., Van Der Heijde D, Braun J, Dougados M, Cush J, Clegg DO, Kivitz A, Fleischmann R, Inman R, Tsuji W, Enbrel Ankylosing Spondylitis Study G. Recombinant human tumor necrosis factor receptor (etanercept) for treating ankylosing spondylitis: A randomized, controlled trial. Arthritis Rheum. 2003; 48:3230-3236.","DOI":"10.1002\/art.11325"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Baeten D, Baraliakos X, Braun J, <i>et al<\/i>. Anti-interleukin-17A monoclonal antibody secukinumab in treatment of ankylosing spondylitis: A randomised, double-blind, placebo-controlled trial. Lancet. 2013; 382:1705-1713.","DOI":"10.1016\/S0140-6736(13)61134-4"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Tam LS, Gu J, Yu D. Pathogenesis of ankylosing spondylitis. Nat Rev Rheumatol. 2010; 6:399-405.","DOI":"10.1038\/nrrheum.2010.79"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Robinson PC, Brown MA. Genetics of ankylosing spondylitis. Mol Immunol. 2014; 57:2-11.","DOI":"10.1016\/j.molimm.2013.06.013"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Brown MA, Kenna T, Wordsworth BP. Genetics of ankylosing spondylitis--insights into pathogenesis. Nat Rev Rheumatol. 2016; 12:81-91.","DOI":"10.1038\/nrrheum.2015.133"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Zhang C, Wang C, Jia Z, Tong W, Liu D, He C, Huang X, Xu W. Differentially expressed mRNAs, lncRNAs, and miRNAs with associated co-expression and ceRNA networks in ankylosing spondylitis. Oncotarget. 2017; 8:113543-113557.","DOI":"10.18632\/oncotarget.22708"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Cabianca DS, Casa V, Gabellini D. A novel molecular mechanism in human genetic disease: A DNA repeat derived lncRNA. RNA Biol. 2012; 9:1211-1217.","DOI":"10.4161\/rna.21922"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Yun-Bo F, Xiao-Po L, Xiao-Li L, Guo-Long C, Pei Z, Fa-Ming T. LncRNA TUG1 is upregulated and promotes cell proliferation in osteosarcoma. Open Med (Wars). 2016; 11:163-167.","DOI":"10.1515\/med-2016-0031"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Lukas C, Landewe R, Sieper J, Dougados M, Davis J, Braun J, van der Linden S, van der Heijde D, Assessment of SpondyloArthritis international S. Development of an ASAS-endorsed disease activity score (ASDAS) in patients with ankylosing spondylitis. Ann Rheum Dis. 2009; 68:18-24.","DOI":"10.1136\/ard.2008.094870"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Choi ST, Kim JH, Kang EJ, Lee SW, Park MC, Park YB, Lee SK. Osteopontin might be involved in bone remodelling rather than in inflammation in ankylosing spondylitis. Rheumatology (Oxford). 2008; 47:1775-1779.","DOI":"10.1093\/rheumatology\/ken385"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Yu C, Li L, Xie F, Guo S, Liu F, Dong N, Wang Y. LncRNA TUG1 sponges miR-204-5p to promote osteoblast differentiation through upregulating Runx2 in aortic valve calcification. Cardiovasc Res. 2018; 114:168-179.","DOI":"10.1093\/cvr\/cvx180"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Viereck J, Thum T. Circulating Noncoding RNAs as Biomarkers of Cardiovascular Disease and Injury. Circ Res. 2017; 120:381-399.","DOI":"10.1161\/CIRCRESAHA.116.308434"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Neppl RL, Wu CL, Walsh K. lncRNA Chronos is an aging-induced inhibitor of muscle hypertrophy. J Cell Biol. 2017; 216:3497-3507.","DOI":"10.1083\/jcb.201612100"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Mayfield RD. Emerging roles for ncRNAs in alcohol use disorders. Alcohol. 2017; 60:31-39.","DOI":"10.1016\/j.alcohol.2017.01.004"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Li S, Sun X, Miao S, Liu J, Jiao W. Differential proteincoding gene and long noncoding RNA expression in smoking-related lung squamous cell carcinoma. Thorac Cancer. 2017; 8:672-681.","DOI":"10.1111\/1759-7714.12510"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Poddubnyy D, Protopopov M, Haibel H, Braun J, Rudwaleit M, Sieper J. High disease activity according to the Ankylosing Spondylitis Disease Activity Score is associated with accelerated radiographic spinal progression in patients with early axial spondyloarthritis: Results from the GErman SPondyloarthritis Inception Cohort. Ann Rheum Dis. 2016; 75:2114-2118.","DOI":"10.1136\/annrheumdis-2016-209209"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Boonen A, van der Heijde D, Landewe R, Guillemin F, Rutten-van Molken M, Dougados M, Mielants H, de Vlam K, van der Tempel H, Boesen S, Spoorenberg A, Schouten H, van der Linden S. Direct costs of ankylosing spondylitis and its determinants: An analysis among three European countries. Ann Rheum Dis. 2003; 62:732-740.","DOI":"10.1136\/ard.62.8.732"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. van Denderen JC, Visman IM, Nurmohamed MT, Suttorp-Schulten MS, van der Horst-Bruinsma IE. Adalimumab significantly reduces the recurrence rate of anterior uveitis in patients with ankylosing spondylitis. J Rheumatol. 2014; 41:1843-1848.","DOI":"10.3899\/jrheum.131289"}],"container-title":["BioScience Trends"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bst\/12\/4\/12_2018.01117\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,23]],"date-time":"2019-10-23T00:08:55Z","timestamp":1571789335000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bst\/12\/4\/12_2018.01117\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,31]]},"references-count":21,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.5582\/bst.2018.01117","relation":{},"ISSN":["1881-7815","1881-7823"],"issn-type":[{"value":"1881-7815","type":"print"},{"value":"1881-7823","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,31]]}}}